{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=completion_date&start=45300","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=completion_date&start=44700","results":[{"registry_id":"NCT07282574","publication_url":"https://clinicaltrials.gov/study/NCT07282574","title":"A Multi-center, Double-blind, Placebo-controlled, Phase II Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489, a Monoacylglycerol Lipase Inhibitor, as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis","has_exemption":false,"start_date":"2026-03-10","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07422311","publication_url":"https://clinicaltrials.gov/study/NCT07422311","title":"A Phase 2/3, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Benuvia Therapeutics Inc.","sponsor_slug":"benuvia-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07527273","publication_url":"https://clinicaltrials.gov/study/NCT07527273","title":"Cognitive Enhancement in Recurrent Depression (The COG-D-R Study)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224711","publication_url":"https://clinicaltrials.gov/study/NCT07224711","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (IMPALA ERAS)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2028-05-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03047746","publication_url":"https://clinicaltrials.gov/study/NCT03047746","title":"Unrelated And Partially Matched Related Donor Peripheral Blood Stem Cell Transplantation (PSCT) With TCR αβ + T Cell And B Cell Depletion For Patients With Acquired And Inherited Bone Marrow Failure","has_exemption":false,"start_date":"2017-02-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03422302","publication_url":"https://clinicaltrials.gov/study/NCT03422302","title":"Measuring the Effectiveness of a Continuous Positive Airway Pressure (CPAP) Device to Reduce Tumor Motion and Increase Lung Volume Expansion in Patients Undergoing Stereotactic Body Radiotherapy (SBRT) for Tumors That Move With Respiration","has_exemption":false,"start_date":"2018-03-16","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03417297","publication_url":"https://clinicaltrials.gov/study/NCT03417297","title":"A Pilot Open-label Clinical Trial Evaluating the ExAblate Model 4000 Type-1 Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy","has_exemption":false,"start_date":"2018-04-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04471974","publication_url":"https://clinicaltrials.gov/study/NCT04471974","title":"A Phase 2 Study of BET Bromodomain Inhibitor ZEN-3694 in Combination With Enzalutamide Plus Pembrolizumab in Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-01-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Rahul Aggarwal","sponsor_slug":"rahul-aggarwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04411654","publication_url":"https://clinicaltrials.gov/study/NCT04411654","title":"An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose LY3884961 in Infants With Type 2 Gaucher Disease","has_exemption":false,"start_date":"2021-06-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Prevail Therapeutics","sponsor_slug":"prevail-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03742414","publication_url":"https://clinicaltrials.gov/study/NCT03742414","title":"SEAL (Stopping Eczema and ALlergy) Study: Prevent the Allergic March by Enhancing the Skin Barrier","has_exemption":false,"start_date":"2021-06-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Kari Nadeau, MD, PhD","sponsor_slug":"kari-nadeau-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05045950","publication_url":"https://clinicaltrials.gov/study/NCT05045950","title":"Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT) - A Phase II Trial of Upfront Pulsed Reduced Dose Rate Whole-Brain Radiation Therapy for Brain Metastases","has_exemption":false,"start_date":"2021-11-17","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284473","publication_url":"https://clinicaltrials.gov/study/NCT06284473","title":"Intranasal Ketamine as a Supplement to Local Anesthesia to Reduce Pain Associated With Minor Procedures in the Emergency Department","has_exemption":false,"start_date":"2022-05-25","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05101070","publication_url":"https://clinicaltrials.gov/study/NCT05101070","title":"A Phase 1b/2, Multicenter, Open-label Study of S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-05-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Shionogi","sponsor_slug":"shionogi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04912531","publication_url":"https://clinicaltrials.gov/study/NCT04912531","title":"Using a Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery","has_exemption":false,"start_date":"2022-10-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05508789","publication_url":"https://clinicaltrials.gov/study/NCT05508789","title":"Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease","has_exemption":false,"start_date":"2022-10-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05528133","publication_url":"https://clinicaltrials.gov/study/NCT05528133","title":"Phase II Study of Genomically Guided Radiation Dose Personalization in the Management of Triple Negative Breast Cancer","has_exemption":false,"start_date":"2023-01-25","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05896293","publication_url":"https://clinicaltrials.gov/study/NCT05896293","title":"Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders","has_exemption":false,"start_date":"2023-02-03","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Stephanie B. Seminara, MD","sponsor_slug":"stephanie-b-seminara-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04796792","publication_url":"https://clinicaltrials.gov/study/NCT04796792","title":"Ultrasound Technology to Fragment and Reposition Urinary Stones","has_exemption":false,"start_date":"2023-04-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05737199","publication_url":"https://clinicaltrials.gov/study/NCT05737199","title":"A Single-arm Open-label Phase II Trial to Assess the Efficacy and Safety of Pembrolizumab for Unresectable Advanced or Recurrent Ovarian Squamous Cell Carcinoma","has_exemption":false,"start_date":"2023-05-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Niigata University Medical & Dental Hospital","sponsor_slug":"niigata-university-medical-dental-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05866536","publication_url":"https://clinicaltrials.gov/study/NCT05866536","title":"Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years","has_exemption":false,"start_date":"2023-05-04","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05943210","publication_url":"https://clinicaltrials.gov/study/NCT05943210","title":"The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer.","has_exemption":false,"start_date":"2023-05-22","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805839","publication_url":"https://clinicaltrials.gov/study/NCT05805839","title":"Advanced MR and PET Imaging in Inflammatory Demyelinating Diseases of the Central Nervous System","has_exemption":false,"start_date":"2023-07-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04419272","publication_url":"https://clinicaltrials.gov/study/NCT04419272","title":"Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits: a Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2023-08-14","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023589","publication_url":"https://clinicaltrials.gov/study/NCT06023589","title":"A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON)","has_exemption":false,"start_date":"2023-08-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948943","publication_url":"https://clinicaltrials.gov/study/NCT05948943","title":"A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.","has_exemption":false,"start_date":"2023-11-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003348","publication_url":"https://clinicaltrials.gov/study/NCT06003348","title":"Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones","has_exemption":false,"start_date":"2023-12-13","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305039","publication_url":"https://clinicaltrials.gov/study/NCT06305039","title":"Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments - Part 2","has_exemption":false,"start_date":"2023-12-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, College Park","sponsor_slug":"university-of-maryland-college-park","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06094192","publication_url":"https://clinicaltrials.gov/study/NCT06094192","title":"Personalized Synchronization of Cortical Rhythms to Improve Memory in Alzheimer's Disease","has_exemption":false,"start_date":"2023-12-20","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston University Charles River Campus","sponsor_slug":"boston-university-charles-river-campus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06347978","publication_url":"https://clinicaltrials.gov/study/NCT06347978","title":"A Double-Blinded, Randomized, Crossover Trial of Stereoencephalography- Guided Four-Lead Personalized Deep Brain Stimulation for Treatment-Refractory Obsessive Compulsive Disorder (SEEG-Guided DBS for OCD)","has_exemption":false,"start_date":"2024-05-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Andrew Moses Lee, MD, PhD","sponsor_slug":"andrew-moses-lee-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06264882","publication_url":"https://clinicaltrials.gov/study/NCT06264882","title":"Cardiometabolic Consequences of the Loss of Ovarian Function","has_exemption":false,"start_date":"2024-06-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205836","publication_url":"https://clinicaltrials.gov/study/NCT06205836","title":"Evaluating a Surgical-Sparing Approach Using Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer","has_exemption":false,"start_date":"2024-06-13","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06389877","publication_url":"https://clinicaltrials.gov/study/NCT06389877","title":"A Phase 1/2 Dose-exploration and Dose-expansion Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease and/or Liver Disease","has_exemption":false,"start_date":"2024-06-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Beam Therapeutics Inc.","sponsor_slug":"beam-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05932199","publication_url":"https://clinicaltrials.gov/study/NCT05932199","title":"Combination of Induction Durvalumab and Tremelimumab Alone Versus Durvalumab and Tremelimumab With Chemotherapy for Potentially Resectable Pleural Mesothelioma","has_exemption":false,"start_date":"2024-07-03","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05662462","publication_url":"https://clinicaltrials.gov/study/NCT05662462","title":"ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching","has_exemption":false,"start_date":"2024-07-11","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961487","publication_url":"https://clinicaltrials.gov/study/NCT06961487","title":"Endovascular Therapy for Large Core Patients With Uncertain Response to Thrombectomy (OUTER LIMITS)","has_exemption":false,"start_date":"2024-07-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06475742","publication_url":"https://clinicaltrials.gov/study/NCT06475742","title":"A Phase 3, Multicenter, Open-label, Single-arm, Extension Study to Evaluate the Long-term Safety and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy","has_exemption":false,"start_date":"2024-07-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06031688","publication_url":"https://clinicaltrials.gov/study/NCT06031688","title":"A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)","has_exemption":false,"start_date":"2024-08-08","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06494072","publication_url":"https://clinicaltrials.gov/study/NCT06494072","title":"Short Versus Standard of Care Antibiotic Duration for Hospitalized Children With Uncomplicated Community-acquired Pneumonia: a Non-inferiority, Randomized Controlled Trial.","has_exemption":false,"start_date":"2024-08-22","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06320366","publication_url":"https://clinicaltrials.gov/study/NCT06320366","title":"Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder","has_exemption":false,"start_date":"2024-09-03","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06334315","publication_url":"https://clinicaltrials.gov/study/NCT06334315","title":"Influence of Genetics Variants on the Pharmacokinetics and Pharmacodynamics of Combined Oral Contraceptive Pill Users","has_exemption":false,"start_date":"2024-10-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06481592","publication_url":"https://clinicaltrials.gov/study/NCT06481592","title":"A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Endometrial Cancer.","has_exemption":false,"start_date":"2024-10-29","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Iovance Biotherapeutics, Inc.","sponsor_slug":"iovance-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116682","publication_url":"https://clinicaltrials.gov/study/NCT06116682","title":"A Phase II Study of Amivantamab SC (Subcutaneous) in Participants With MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)","has_exemption":false,"start_date":"2024-11-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06617325","publication_url":"https://clinicaltrials.gov/study/NCT06617325","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2024-11-21","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06674577","publication_url":"https://clinicaltrials.gov/study/NCT06674577","title":"A Multicenter, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept","has_exemption":false,"start_date":"2024-12-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Vera Therapeutics, Inc.","sponsor_slug":"vera-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630234","publication_url":"https://clinicaltrials.gov/study/NCT06630234","title":"A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)","has_exemption":false,"start_date":"2024-12-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Deciphera Pharmaceuticals LLC","sponsor_slug":"deciphera-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533748","publication_url":"https://clinicaltrials.gov/study/NCT06533748","title":"SJALL23H: Combination Antigen-Directed Induction Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma","has_exemption":false,"start_date":"2025-01-23","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06857942","publication_url":"https://clinicaltrials.gov/study/NCT06857942","title":"A Phase 4, Prospective, Open-Label, Single Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight in Clinical Practice","has_exemption":false,"start_date":"2025-03-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07353957","publication_url":"https://clinicaltrials.gov/study/NCT07353957","title":"A Phase 2 Study to Investigate the Safety and Efficacy of Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer in Combination With Pembrolizumab as First-Line Treatment","has_exemption":false,"start_date":"2025-03-27","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Merus B.V.","sponsor_slug":"merus-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827236","publication_url":"https://clinicaltrials.gov/study/NCT06827236","title":"A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer","has_exemption":false,"start_date":"2025-04-23","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976853","publication_url":"https://clinicaltrials.gov/study/NCT06976853","title":"Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease","has_exemption":false,"start_date":"2025-05-13","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06984861","publication_url":"https://clinicaltrials.gov/study/NCT06984861","title":"Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Advanced Stage Human Papilloma Virus Associated Oropharyngeal Carcinoma","has_exemption":false,"start_date":"2025-05-13","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06986083","publication_url":"https://clinicaltrials.gov/study/NCT06986083","title":"A Randomized Controlled Trial of Modifications to Prostate Needle-Based Procedures","has_exemption":false,"start_date":"2025-05-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424365","publication_url":"https://clinicaltrials.gov/study/NCT07424365","title":"Investigation of Vagus Nerve Stimulation to Augment Executive Functioning","has_exemption":false,"start_date":"2025-05-19","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06072898","publication_url":"https://clinicaltrials.gov/study/NCT06072898","title":"Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression","has_exemption":false,"start_date":"2025-05-28","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Sunnybrook Health Sciences Centre","sponsor_slug":"sunnybrook-health-sciences-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06821542","publication_url":"https://clinicaltrials.gov/study/NCT06821542","title":"A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy","has_exemption":false,"start_date":"2025-06-04","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07038200","publication_url":"https://clinicaltrials.gov/study/NCT07038200","title":"A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)","has_exemption":false,"start_date":"2025-06-10","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937099","publication_url":"https://clinicaltrials.gov/study/NCT06937099","title":"A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight","has_exemption":false,"start_date":"2025-06-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925152","publication_url":"https://clinicaltrials.gov/study/NCT06925152","title":"COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block","has_exemption":false,"start_date":"2025-07-15","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Tennessee","sponsor_slug":"university-of-tennessee","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06911632","publication_url":"https://clinicaltrials.gov/study/NCT06911632","title":"MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion)","has_exemption":false,"start_date":"2025-07-23","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Tempus AI","sponsor_slug":"tempus-ai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06853184","publication_url":"https://clinicaltrials.gov/study/NCT06853184","title":"Phase 2, Randomized, Open-label, Active Comparator, Dose-ranging Study Evaluating the Efficacy and Safety of Artesunate for Injection in Combination With Ganciclovir or Valganciclovir for the Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients","has_exemption":false,"start_date":"2025-08-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Amivas Inc.","sponsor_slug":"amivas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07133308","publication_url":"https://clinicaltrials.gov/study/NCT07133308","title":"A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients With Severe Alopecia Areata With an Open-label Extension Period","has_exemption":false,"start_date":"2025-08-05","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries, Inc.","sponsor_slug":"sun-pharmaceutical-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020312","publication_url":"https://clinicaltrials.gov/study/NCT07020312","title":"Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery: A Blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2025-08-14","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07086976","publication_url":"https://clinicaltrials.gov/study/NCT07086976","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)","has_exemption":false,"start_date":"2025-08-18","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07131787","publication_url":"https://clinicaltrials.gov/study/NCT07131787","title":"Optimizing Rehabilitation After Achilles Tendon Rupture Repair: The Role of Blood Flow Restriction Training in Tendon and Muscle Recovery","has_exemption":false,"start_date":"2025-08-20","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Ghent","sponsor_slug":"university-hospital-ghent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06624475","publication_url":"https://clinicaltrials.gov/study/NCT06624475","title":"Randomized Phase II Trial Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma","has_exemption":false,"start_date":"2025-08-21","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07053059","publication_url":"https://clinicaltrials.gov/study/NCT07053059","title":"Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)","has_exemption":false,"start_date":"2025-08-26","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287163","publication_url":"https://clinicaltrials.gov/study/NCT07287163","title":"Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy","has_exemption":false,"start_date":"2025-10-27","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Praxis Precision Medicines","sponsor_slug":"praxis-precision-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07198451","publication_url":"https://clinicaltrials.gov/study/NCT07198451","title":"Efficacy Evaluation of Submucosal Injection of Gemcitabine in Preventing Recurrence of Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized, Single-Blind, Multicenter Clinical Study","has_exemption":false,"start_date":"2025-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Shanghai University of Traditional Chinese Medicine","sponsor_slug":"shanghai-university-of-traditional-chinese-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228832","publication_url":"https://clinicaltrials.gov/study/NCT07228832","title":"A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination With FOLFOX Versus Bevacizumab in Combination With FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2025-11-18","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Summit Therapeutics","sponsor_slug":"summit-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07392255","publication_url":"https://clinicaltrials.gov/study/NCT07392255","title":"A First in Human Phase 1 / 2 Multi-center Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of CTx001 Administered Via a Single Subretinal Injection in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Complement Therapeutics","sponsor_slug":"complement-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284459","publication_url":"https://clinicaltrials.gov/study/NCT07284459","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2026-01-08","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Contineum Therapeutics","sponsor_slug":"contineum-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07308925","publication_url":"https://clinicaltrials.gov/study/NCT07308925","title":"Effectiveness of Using Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.","has_exemption":false,"start_date":"2026-01-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitario San Ignacio","sponsor_slug":"hospital-universitario-san-ignacio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325500","publication_url":"https://clinicaltrials.gov/study/NCT07325500","title":"Incretin Microdosing for Cardiometabolic Health in People With HIV: The REINFORCE Trial","has_exemption":false,"start_date":"2026-02-12","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06667726","publication_url":"https://clinicaltrials.gov/study/NCT06667726","title":"A Centralized Protocol Evaluating the Safety and Clinical Impact of Amino Acid Pet for Brain Tumors","has_exemption":false,"start_date":"2026-03-24","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07527039","publication_url":"https://clinicaltrials.gov/study/NCT07527039","title":"Intraoperative Pectoral Block in Breast Reductions: Reduction in Pain Scores & Elimination of Narcotic Use","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076212","publication_url":"https://clinicaltrials.gov/study/NCT07076212","title":"Phase II Study Evaluating NALIRIFOX Versus Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-04-02","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523750","publication_url":"https://clinicaltrials.gov/study/NCT07523750","title":"Comparison of Safety and Effectiveness of a VARIPULSE™ PFA Catheter to FARAWAVE™ PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-04-06","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07525076","publication_url":"https://clinicaltrials.gov/study/NCT07525076","title":"Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department","has_exemption":false,"start_date":"2026-04-15","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07506018","publication_url":"https://clinicaltrials.gov/study/NCT07506018","title":"A Phase II Open-Label Trial of MucoLock™ Oral Rinse for the Treatment of Stomatitis Characterized by Oral Dysesthesia","has_exemption":false,"start_date":"2026-04-15","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07546500","publication_url":"https://clinicaltrials.gov/study/NCT07546500","title":"A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator's Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression","has_exemption":false,"start_date":"2026-04-15","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc","sponsor_slug":"k-group-beta-inc-a-wholly-owned-subsidiary-of-zentalis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979492","publication_url":"https://clinicaltrials.gov/study/NCT06979492","title":"Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542041","publication_url":"https://clinicaltrials.gov/study/NCT07542041","title":"Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens (ANoPs)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"ARTIDIS AG","sponsor_slug":"artidis-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05874193","publication_url":"https://clinicaltrials.gov/study/NCT05874193","title":"A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Cristiana Costa Chase, DO","sponsor_slug":"cristiana-costa-chase-do","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290998","publication_url":"https://clinicaltrials.gov/study/NCT07290998","title":"A Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Locally Recurrent Prostate Cancer","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Alpha Tau Medical LTD.","sponsor_slug":"alpha-tau-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07383649","publication_url":"https://clinicaltrials.gov/study/NCT07383649","title":"Initial Safety Lead-in Followed by a Phase II Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection (The Breast CMV Study)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07458113","publication_url":"https://clinicaltrials.gov/study/NCT07458113","title":"Sacituzumab Tirumotecan to Treat Patients With Brain Metastases From Triple-negative Breast Cancer","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07459114","publication_url":"https://clinicaltrials.gov/study/NCT07459114","title":"An Adaptive Dose Escalation and Expansion Basket Trial to Explore the Safety, Pharmacology, and Clinical Activity of TGD001 in Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) and Other Thrombotic Microangiopathies","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"TargED Biopharmaceuticals B.V.","sponsor_slug":"targed-biopharmaceuticals-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07484139","publication_url":"https://clinicaltrials.gov/study/NCT07484139","title":"H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07483177","publication_url":"https://clinicaltrials.gov/study/NCT07483177","title":"Hemodynamic Effects Of Aldosterone Receptor Blockade In Degenerative Thoracic Aortic Aneurysm: A Pilot Randomized Controlled Trial (HEART: Pilot RCT)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07485647","publication_url":"https://clinicaltrials.gov/study/NCT07485647","title":"Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Eden Biltibo","sponsor_slug":"eden-biltibo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07510945","publication_url":"https://clinicaltrials.gov/study/NCT07510945","title":"A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3b Clinical Study to Evaluate the Efficacy and Safety of HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","sponsor_slug":"haisco-pharmaceutical-group-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07494773","publication_url":"https://clinicaltrials.gov/study/NCT07494773","title":"Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection: A Prospective Randomized Pilot Study","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325201","publication_url":"https://clinicaltrials.gov/study/NCT07325201","title":"Mitigating Diabetic Ketoacidosis in People With T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation Into an Enhanced Glucose Ketone Report","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"HealthPartners Institute","sponsor_slug":"healthpartners-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07247162","publication_url":"https://clinicaltrials.gov/study/NCT07247162","title":"A Double-blind, Randomised, 30-week Placebo-controlled Phase IV Study to Assess the Efficacy and Safety of Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"RECORDATI GROUP","sponsor_slug":"recordati-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06550999","publication_url":"https://clinicaltrials.gov/study/NCT06550999","title":"Patient Satisfaction and Cosmetic Outcomes in Adhesive Strip Versus Suture Repair for Simple Facial Lacerations: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07458217","publication_url":"https://clinicaltrials.gov/study/NCT07458217","title":"Combined CM and STN Stimulation for Motor Epilepsy","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00882895","publication_url":"https://clinicaltrials.gov/study/NCT00882895","title":"Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2009-05-05","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01950351","publication_url":"https://clinicaltrials.gov/study/NCT01950351","title":"Phase II Trial of Hypofractionated Proton Beam Therapy in Men With Localized Prostate Adenocarcinoma","has_exemption":false,"start_date":"2013-10-10","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03080974","publication_url":"https://clinicaltrials.gov/study/NCT03080974","title":"Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2017-08-14","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05381103","publication_url":"https://clinicaltrials.gov/study/NCT05381103","title":"PSMA-PET to Guide Prostatectomy: A Randomized Trial","has_exemption":false,"start_date":"2021-10-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Five Eleven Pharma, Inc.","sponsor_slug":"five-eleven-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04883671","publication_url":"https://clinicaltrials.gov/study/NCT04883671","title":"Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial","has_exemption":false,"start_date":"2021-12-27","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05928936","publication_url":"https://clinicaltrials.gov/study/NCT05928936","title":"Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD","has_exemption":false,"start_date":"2022-11-11","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06027879","publication_url":"https://clinicaltrials.gov/study/NCT06027879","title":"Anti-viral T-cell Therapy by Gamma Capture for High-risk Patients With Acquired or Inherited Immune Defects","has_exemption":false,"start_date":"2024-01-08","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Paul Szabolcs","sponsor_slug":"paul-szabolcs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06150560","publication_url":"https://clinicaltrials.gov/study/NCT06150560","title":"A Phase III, Randomized, Double-Blind, Placebo Controlled Clinical Trial Evaluating the Benefits and Mechanism Of Action Of Angiotensin-II Receptor Blocker On Cardiovascular Remodeling In Patients With Repaired Coarctation Of Aorta","has_exemption":false,"start_date":"2024-04-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06610305","publication_url":"https://clinicaltrials.gov/study/NCT06610305","title":"Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression: A Crossover Randomized Controlled Trial","has_exemption":false,"start_date":"2024-09-02","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06070350","publication_url":"https://clinicaltrials.gov/study/NCT06070350","title":"Massive Transfusion in Children: a Platform RCT of Whole Blood Compared to Component Therapy and Tranexamic Acid to Placebo in Life-threatening Traumatic Bleeding","has_exemption":false,"start_date":"2024-11-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Philip Spinella","sponsor_slug":"philip-spinella","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06731478","publication_url":"https://clinicaltrials.gov/study/NCT06731478","title":"A Multicenter, Randomized, Open-Label, Phase 3 Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab Versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab as First-Line Treatment in Participants With Unresectable, Locally Advanced or Metastatic HER2-Positive Gastric Or Gastroesophageal Junction (GEJ) Cancer (Destiny-Gastric05)","has_exemption":false,"start_date":"2025-02-27","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06644781","publication_url":"https://clinicaltrials.gov/study/NCT06644781","title":"A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)","has_exemption":false,"start_date":"2025-03-27","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06397274","publication_url":"https://clinicaltrials.gov/study/NCT06397274","title":"A Phase II, Randomized, Double-Blind, Placebo-controlled, Single-Center Study to Evaluate the Safety and Efficacy of Stemchymal (Allogeneic Adipose-derived Mesenchymal Stem Cells) Infusion for the Treatment of PolyQ Spinocerebellar Ataxia","has_exemption":false,"start_date":"2025-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Steminent US, Inc.","sponsor_slug":"steminent-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07071402","publication_url":"https://clinicaltrials.gov/study/NCT07071402","title":"A Single-center, Single-arm, Open Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery","has_exemption":false,"start_date":"2025-07-18","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Xijing Hospital","sponsor_slug":"xijing-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07058012","publication_url":"https://clinicaltrials.gov/study/NCT07058012","title":"A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab and Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy","has_exemption":false,"start_date":"2025-08-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"NSABP Foundation Inc","sponsor_slug":"nsabp-foundation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06503146","publication_url":"https://clinicaltrials.gov/study/NCT06503146","title":"18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection","has_exemption":false,"start_date":"2025-09-09","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07198724","publication_url":"https://clinicaltrials.gov/study/NCT07198724","title":"ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer","has_exemption":false,"start_date":"2025-11-17","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Sarah Sammons, MD","sponsor_slug":"sarah-sammons-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287839","publication_url":"https://clinicaltrials.gov/study/NCT07287839","title":"Phase-2 Trial of Parcel-guided rTMS for Major Depressive Disorder","has_exemption":false,"start_date":"2025-12-15","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Soterix Medical","sponsor_slug":"soterix-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07274787","publication_url":"https://clinicaltrials.gov/study/NCT07274787","title":"An Open Label, Prospective, Pilot Study To Evaluate The Safety And Effectiveness Of The NaviFUS System In Conjunction With A Standard Treatment Regimen Of Bevacizumab (BEV) In Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2026-01-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290985","publication_url":"https://clinicaltrials.gov/study/NCT07290985","title":"AACR Adaptive Biomarker-Driven Organ Preservation Trial In Gastroesophageal Adenocarcinomas (AACR-ADOPT-GEA)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"American Association for Cancer Research","sponsor_slug":"american-association-for-cancer-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07349771","publication_url":"https://clinicaltrials.gov/study/NCT07349771","title":"Phase II Double-Blinded Placebo-Controlled Randomized Trial of CSF-1R Inhibitor, Axatilimab for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07438626","publication_url":"https://clinicaltrials.gov/study/NCT07438626","title":"Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07494435","publication_url":"https://clinicaltrials.gov/study/NCT07494435","title":"An Open-Label Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma or Advance Renal Cell Carcinoma","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"Zhejiang Haichang Biotech Co., Ltd.","sponsor_slug":"zhejiang-haichang-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07507214","publication_url":"https://clinicaltrials.gov/study/NCT07507214","title":"Optimized, Neuroplasticity Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04747236","publication_url":"https://clinicaltrials.gov/study/NCT04747236","title":"A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)","has_exemption":false,"start_date":"2021-02-19","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05312879","publication_url":"https://clinicaltrials.gov/study/NCT05312879","title":"A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease","has_exemption":false,"start_date":"2022-03-30","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05481827","publication_url":"https://clinicaltrials.gov/study/NCT05481827","title":"ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study","has_exemption":false,"start_date":"2022-07-12","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"Gyroscope Therapeutics Limited","sponsor_slug":"gyroscope-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07392970","publication_url":"https://clinicaltrials.gov/study/NCT07392970","title":"A Pilot Clinical Trial of Motixafortide for Measurable Residual Disease (MRD) Sensitization in Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2028-06-02","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06769698","publication_url":"https://clinicaltrials.gov/study/NCT06769698","title":"Phase II Randomized Study of Fianlimab Plus Cemiplimab Versus Cemiplimab Plus Placebo in First-Line Treatment of Participants With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Is Positive for PD-L1 Expression","has_exemption":false,"start_date":"2026-03-31","completion_date":"2028-06-04","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07014917","publication_url":"https://clinicaltrials.gov/study/NCT07014917","title":"Randomized Phase II Study of Intermittent Versus Continuous Venetoclax Therapy With Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This","has_exemption":false,"start_date":"2025-12-05","completion_date":"2028-06-05","has_results":false,"results_due":false,"sponsor_name":"Zulfa Omer","sponsor_slug":"zulfa-omer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453876","publication_url":"https://clinicaltrials.gov/study/NCT06453876","title":"Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-06-05","has_results":false,"results_due":false,"sponsor_name":"Jesper Kjaergaard","sponsor_slug":"jesper-kjaergaard","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824168","publication_url":"https://clinicaltrials.gov/study/NCT06824168","title":"A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia in Complete Remission","has_exemption":false,"start_date":"2025-07-18","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07088068","publication_url":"https://clinicaltrials.gov/study/NCT07088068","title":"A Randomized, Double-blind, Phase 3 Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Recently Diagnosed Stage 3 Type 1 Diabetes (T1D)","has_exemption":false,"start_date":"2025-08-06","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06794229","publication_url":"https://clinicaltrials.gov/study/NCT06794229","title":"A Phase II, Open-label, Single-arm Study of nEoadjuvant Zanzalintinib (XL092) Plus nivoLumab in Patients With lOcally Advanced and/or inopeRable clEar Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis (EXPLORE-RCC)","has_exemption":false,"start_date":"2025-10-30","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Qian Qin","sponsor_slug":"qian-qin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07503210","publication_url":"https://clinicaltrials.gov/study/NCT07503210","title":"Efficacy and Safety of NNC0487-0111 s.c. Once Weekly in Participants With Obesity Who Have Reached Target Dose During run-in Period (AMAZE 12)","has_exemption":false,"start_date":"2026-04-21","completion_date":"2028-06-06","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07169578","publication_url":"https://clinicaltrials.gov/study/NCT07169578","title":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)","has_exemption":false,"start_date":"2025-09-17","completion_date":"2028-06-07","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07170150","publication_url":"https://clinicaltrials.gov/study/NCT07170150","title":"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)","has_exemption":false,"start_date":"2025-11-12","completion_date":"2028-06-07","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07421167","publication_url":"https://clinicaltrials.gov/study/NCT07421167","title":"A Phase 2 Open-label Study to Evaluate the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least One Treatment (VAY2EXPLORE)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-06-09","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06902272","publication_url":"https://clinicaltrials.gov/study/NCT06902272","title":"A Phase 2 Study of Circulating Tumor DNA to Predict Response to Neoadjuvant Treatment and De-escalation Adjuvant Immunotherapy in Early-Stage NSCLC (DNA-PREDICT)","has_exemption":false,"start_date":"2025-06-11","completion_date":"2028-06-11","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06467357","publication_url":"https://clinicaltrials.gov/study/NCT06467357","title":"DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig Versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer","has_exemption":false,"start_date":"2024-08-12","completion_date":"2028-06-12","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07007637","publication_url":"https://clinicaltrials.gov/study/NCT07007637","title":"A Phase 3, Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-27","completion_date":"2028-06-13","has_results":false,"results_due":false,"sponsor_name":"MoonLake Immunotherapeutics AG","sponsor_slug":"moonlake-immunotherapeutics-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06929273","publication_url":"https://clinicaltrials.gov/study/NCT06929273","title":"A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)","has_exemption":false,"start_date":"2025-07-18","completion_date":"2028-06-13","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05039619","publication_url":"https://clinicaltrials.gov/study/NCT05039619","title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescent Patients With Active Class III or IV Lupus Nephritis, Including an Evaluation of Open Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to < 12)","has_exemption":false,"start_date":"2022-05-12","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04930653","publication_url":"https://clinicaltrials.gov/study/NCT04930653","title":"A Phase II Study of Combination Extracorporeal Photopheresis (ECP) and Mogamulizumab in Erythrodermic CTCL","has_exemption":false,"start_date":"2022-10-19","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327686","publication_url":"https://clinicaltrials.gov/study/NCT05327686","title":"Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)","has_exemption":false,"start_date":"2023-02-01","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"NRG Oncology","sponsor_slug":"nrg-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05616793","publication_url":"https://clinicaltrials.gov/study/NCT05616793","title":"An Open Label, Dose Exploration, Safety and Tolerability Study of a Subretinal Injection of an OPGx-001 Gene Vector to Participants With LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) With OCncurrent Non-Interventional Follow-Up of Untreated Patients","has_exemption":false,"start_date":"2023-06-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Opus Genetics, Inc","sponsor_slug":"opus-genetics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05096481","publication_url":"https://clinicaltrials.gov/study/NCT05096481","title":"Phase 2 Trial of a Novel Peptide Vaccine (PEP-CMV) Targeting CMV Antigen for Newly Diagnosed Pediatric High-grade Glioma and Diffuse Intrinsic Pontine Glioma and Recurrent Medulloblastoma","has_exemption":false,"start_date":"2024-07-18","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06459180","publication_url":"https://clinicaltrials.gov/study/NCT06459180","title":"A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (TroFuse-020/GOG-3101/ENGOT-cx20)","has_exemption":false,"start_date":"2024-07-24","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06506279","publication_url":"https://clinicaltrials.gov/study/NCT06506279","title":"Motor Recovery Through Plasticity-Inducing Cortical Stimulation","has_exemption":false,"start_date":"2025-07-22","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06738407","publication_url":"https://clinicaltrials.gov/study/NCT06738407","title":"Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Among Adolescent and Young Adult Females in the United States","has_exemption":false,"start_date":"2026-01-05","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Westat","sponsor_slug":"westat","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07304440","publication_url":"https://clinicaltrials.gov/study/NCT07304440","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","has_exemption":false,"start_date":"2026-01-12","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Adia Med of Winter Park LLC","sponsor_slug":"adia-med-of-winter-park-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290609","publication_url":"https://clinicaltrials.gov/study/NCT06290609","title":"Control of Incomplete Spinal Cord Injury-Related Spasticity by Means of Vibrotactile Coordinated Reset Fingertip Stimulation","has_exemption":false,"start_date":"2026-03-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293260","publication_url":"https://clinicaltrials.gov/study/NCT07293260","title":"A Double-blind, Randomized, Placebo-controlled, Multi-center Study Evaluating the Safety, Tolerability, and Effect of Olpasiran on Coronary Artery Plaque Burden Assessed by Coronary Computed Tomography Angiography in Participants With Stable Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)","has_exemption":false,"start_date":"2026-03-23","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07167862","publication_url":"https://clinicaltrials.gov/study/NCT07167862","title":"Optimizing Preeclampsia Postpartum With Point-of-Care Ultrasound: A Pilot Prospective Cohort Study","has_exemption":false,"start_date":"2026-06-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07512362","publication_url":"https://clinicaltrials.gov/study/NCT07512362","title":"A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to Patients Treated With Anti-Amyloid Monoclonal Antibodies Who Are Suffering From Mild Cognitive Impairment or Mild Alzheimer's Disease.","has_exemption":false,"start_date":"2026-06-15","completion_date":"2028-06-15","has_results":false,"results_due":false,"sponsor_name":"Bernard (Barry) Baumel","sponsor_slug":"bernard-barry-baumel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02621021","publication_url":"https://clinicaltrials.gov/study/NCT02621021","title":"A Phase II Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab","has_exemption":false,"start_date":"2015-12-04","completion_date":"2028-06-16","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05904080","publication_url":"https://clinicaltrials.gov/study/NCT05904080","title":"Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy","has_exemption":false,"start_date":"2024-02-19","completion_date":"2028-06-16","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925750","publication_url":"https://clinicaltrials.gov/study/NCT06925750","title":"An Open-label Extension Study to Evaluate Safety and Tolerability of Sotatercept (MK-7962) Administered Using a Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care","has_exemption":false,"start_date":"2025-05-12","completion_date":"2028-06-16","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221812","publication_url":"https://clinicaltrials.gov/study/NCT07221812","title":"Continuous Glucose Monitors (CGMs) and Readmission Rates","has_exemption":false,"start_date":"2026-06-18","completion_date":"2028-06-17","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06971744","publication_url":"https://clinicaltrials.gov/study/NCT06971744","title":"Autophagy Maintenance (AUTOMAIN) Therapy in High-Grade Serous Ovarian Cancer: A Phase II Trial","has_exemption":false,"start_date":"2025-12-18","completion_date":"2028-06-18","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07112378","publication_url":"https://clinicaltrials.gov/study/NCT07112378","title":"A Randomized Study Evaluating 2 Dose Regimens of Dupilumab in Children ≥6 Months of Age Weighing ≥5 to <15 kg With Active Eosinophilic Esophagitis","has_exemption":false,"start_date":"2025-11-10","completion_date":"2028-06-19","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07509307","publication_url":"https://clinicaltrials.gov/study/NCT07509307","title":"Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 6)","has_exemption":false,"start_date":"2026-04-13","completion_date":"2028-06-19","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431177","publication_url":"https://clinicaltrials.gov/study/NCT07431177","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Phase IIb Study to Assess the Efficacy and Safety of GIA632 in Adult Participants With Non-segmental Vitiligo Followed by an Extension Period","has_exemption":false,"start_date":"2026-03-09","completion_date":"2028-06-23","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07444476","publication_url":"https://clinicaltrials.gov/study/NCT07444476","title":"An Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Salanersen (BIIB115) in Participants Aged 15-60 Years With Spinal Muscular Atrophy Who Are Either Treatment-Naïve or Have Previously Been Treated With Risdiplam","has_exemption":false,"start_date":"2026-04-03","completion_date":"2028-06-23","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06747351","publication_url":"https://clinicaltrials.gov/study/NCT06747351","title":"A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","has_exemption":false,"start_date":"2025-05-06","completion_date":"2028-06-25","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04464226","publication_url":"https://clinicaltrials.gov/study/NCT04464226","title":"An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies","has_exemption":false,"start_date":"2020-10-20","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04603807","publication_url":"https://clinicaltrials.gov/study/NCT04603807","title":"Randomized, Open Label, Multicenter, Phase III Study of Entrectinib Versus Crizotinib in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer Harboring ROS1 Gene Rearrangements With and Without Central Nervous System Metastases","has_exemption":false,"start_date":"2021-09-30","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06180278","publication_url":"https://clinicaltrials.gov/study/NCT06180278","title":"A Long-term, Open-label, Low-interventional Safety Study of Inebilizumab in the Treatment of NMOSD (N-MOmentum LT)","has_exemption":false,"start_date":"2024-04-02","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925737","publication_url":"https://clinicaltrials.gov/study/NCT06925737","title":"A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)","has_exemption":false,"start_date":"2025-05-13","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07107945","publication_url":"https://clinicaltrials.gov/study/NCT07107945","title":"A Randomised, Double-blind, Placebo-controlled Trial With an Open-label Extension to Assess the Pharmacokinetics, Safety, and Efficacy of Empagliflozin Tablets in Paediatric Patients With Chronic Kidney Disease (EMPA-KIDNEY® Kids)","has_exemption":false,"start_date":"2025-12-09","completion_date":"2028-06-26","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06780670","publication_url":"https://clinicaltrials.gov/study/NCT06780670","title":"PSMAcTION: A Phase II/III, Open-label, International, Multicenter, Randomized Study of AAA817 Versus Standard of Care in the Treatment of Adult Participants With PSMA Positive Metastatic Castration-resistant Prostate Cancer Who Progressed on or After [177Lu]Lu-PSMA Targeted Therapy","has_exemption":false,"start_date":"2025-02-27","completion_date":"2028-06-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06319820","publication_url":"https://clinicaltrials.gov/study/NCT06319820","title":"A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations","has_exemption":false,"start_date":"2024-04-18","completion_date":"2028-06-28","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07190196","publication_url":"https://clinicaltrials.gov/study/NCT07190196","title":"A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease","has_exemption":false,"start_date":"2025-09-26","completion_date":"2028-06-28","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218770","publication_url":"https://clinicaltrials.gov/study/NCT07218770","title":"A Phase 1/2a Study of REGN7041 (Anti-CD3 Monoclonal Antibody) in Participants With Active Noninfectious Uveitis Affecting the Posterior Segment","has_exemption":false,"start_date":"2025-12-17","completion_date":"2028-06-28","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224360","publication_url":"https://clinicaltrials.gov/study/NCT07224360","title":"Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease","has_exemption":false,"start_date":"2026-02-02","completion_date":"2028-06-29","has_results":false,"results_due":false,"sponsor_name":"CSL Behring","sponsor_slug":"csl-behring","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01000350","publication_url":"https://clinicaltrials.gov/study/NCT01000350","title":"Intravenous Saline on Exercise Tolerance in Orthostatic Intolerance","has_exemption":false,"start_date":"2009-10-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02064673","publication_url":"https://clinicaltrials.gov/study/NCT02064673","title":"Randomized Trial of Adjuvant Curcumin After Prostatectomy","has_exemption":false,"start_date":"2014-05-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Yair Lotan","sponsor_slug":"yair-lotan","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03767348","publication_url":"https://clinicaltrials.gov/study/NCT03767348","title":"An Open-Label, Multicenter, Phase 1/2 Study of RP1 as a Single Agent and in Combination With PD1 Blockade in Patients With Solid Tumors [IGNYTE]","has_exemption":false,"start_date":"2017-09-20","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Replimune Inc.","sponsor_slug":"replimune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01818661","publication_url":"https://clinicaltrials.gov/study/NCT01818661","title":"Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech","has_exemption":false,"start_date":"2018-07-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03539822","publication_url":"https://clinicaltrials.gov/study/NCT03539822","title":"A Phase I/II Trial of Cabozantinib in Combination With Durvalumab (MEDI4736) With or Without Tremelimumab in Patients With Advanced Gastroesophageal Cancer and Other Gastrointestinal (GI) Malignancies (CAMILLA)","has_exemption":false,"start_date":"2018-10-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Anwaar Saeed","sponsor_slug":"anwaar-saeed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03708224","publication_url":"https://clinicaltrials.gov/study/NCT03708224","title":"A Phase II Study of Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2019-03-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Alain Algazi","sponsor_slug":"alain-algazi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03933631","publication_url":"https://clinicaltrials.gov/study/NCT03933631","title":"A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery","has_exemption":false,"start_date":"2019-05-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03970447","publication_url":"https://clinicaltrials.gov/study/NCT03970447","title":"GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM","has_exemption":false,"start_date":"2019-07-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03971487","publication_url":"https://clinicaltrials.gov/study/NCT03971487","title":"Ocrelizumab for Psychoses Possibly Caused by Synaptic Autoimmunity","has_exemption":false,"start_date":"2019-10-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115254","publication_url":"https://clinicaltrials.gov/study/NCT04115254","title":"A Master Protocol of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART)","has_exemption":false,"start_date":"2019-10-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04553523","publication_url":"https://clinicaltrials.gov/study/NCT04553523","title":"The Hydrus® Microstent New Enrollment Post-Approval Study: A Prospective, Non-Randomized, Multicenter, Single Arm, Clinical Trial","has_exemption":false,"start_date":"2020-08-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04543071","publication_url":"https://clinicaltrials.gov/study/NCT04543071","title":"A Phase 2 Study With Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Chemokine (C-X-C) Motif Receptor 4 Inhibitor (BL-8040), and Immune Checkpoint Blockade (Cemiplimab) in METastatic Treatment naïve PANCreas Adenocarcinoma","has_exemption":false,"start_date":"2020-11-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Gulam Manji","sponsor_slug":"gulam-manji","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04005469","publication_url":"https://clinicaltrials.gov/study/NCT04005469","title":"A Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney Transplantation","has_exemption":false,"start_date":"2020-11-13","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04546399","publication_url":"https://clinicaltrials.gov/study/NCT04546399","title":"A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged &gt;/= 1 to &lt; 31 Years Old With First Relapse","has_exemption":false,"start_date":"2020-12-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04576156","publication_url":"https://clinicaltrials.gov/study/NCT04576156","title":"A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients With Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/R) to Janus Kinase (JAK) Inhibitor","has_exemption":false,"start_date":"2021-04-12","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Geron Corporation","sponsor_slug":"geron-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04977453","publication_url":"https://clinicaltrials.gov/study/NCT04977453","title":"A Phase 1/2, Open-label, Dose-escalation, Dose-optimization and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Therapeutic Activity of GI-101/GI-101A as a Single Agent and in Combination With Pembrolizumab or Lenvatinib in Patients With Advanced or Metastatic Solid Tumors (Keynote B59)","has_exemption":false,"start_date":"2021-08-02","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"GI Innovation, Inc.","sponsor_slug":"gi-innovation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851119","publication_url":"https://clinicaltrials.gov/study/NCT04851119","title":"A Phase 1/2 Study of Tegavivint (NSC#826393) in Children, Adolescents, and Young Adults With Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors","has_exemption":false,"start_date":"2021-11-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04838041","publication_url":"https://clinicaltrials.gov/study/NCT04838041","title":"Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation","has_exemption":false,"start_date":"2021-11-11","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04873037","publication_url":"https://clinicaltrials.gov/study/NCT04873037","title":"A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Overactive Bladder","has_exemption":false,"start_date":"2021-11-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04892173","publication_url":"https://clinicaltrials.gov/study/NCT04892173","title":"A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With Locally Advanced Head & Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2021-12-10","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Johnson & Johnson Enterprise Innovation Inc.","sponsor_slug":"johnson-johnson-enterprise-innovation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04500756","publication_url":"https://clinicaltrials.gov/study/NCT04500756","title":"LIMItIng AAA With meTformin (LIMIT) Trial","has_exemption":false,"start_date":"2022-02-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05249634","publication_url":"https://clinicaltrials.gov/study/NCT05249634","title":"Effect of JATENZO® Therapy on Testosterone and Hemoglobin Concentrations in Hypogonadal Men with Chronic Kidney Disease","has_exemption":false,"start_date":"2022-03-15","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"St. Louis University","sponsor_slug":"st-louis-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05208190","publication_url":"https://clinicaltrials.gov/study/NCT05208190","title":"Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial","has_exemption":false,"start_date":"2022-03-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05147792","publication_url":"https://clinicaltrials.gov/study/NCT05147792","title":"An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion","has_exemption":false,"start_date":"2022-05-26","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Conformal Medical, Inc","sponsor_slug":"conformal-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05296070","publication_url":"https://clinicaltrials.gov/study/NCT05296070","title":"A Phase 2, Open-label, Study Evaluating Safety and Efficacy of the Loncastuximab in Relapsed/Refractory Marginal Zone Lymphoma","has_exemption":false,"start_date":"2022-06-21","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05502237","publication_url":"https://clinicaltrials.gov/study/NCT05502237","title":"A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations","has_exemption":false,"start_date":"2022-10-12","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05645536","publication_url":"https://clinicaltrials.gov/study/NCT05645536","title":"Open-label, Safety Extension Study for Subjects With HR+, HER2-Negative Breast Cancer Who Have Completed the OVarian Suppression Evaluating Subcutaneous LeuprolIde Acetate in Breast Cancer OVELIA Study","has_exemption":false,"start_date":"2022-12-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Tolmar Inc.","sponsor_slug":"tolmar-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05580562","publication_url":"https://clinicaltrials.gov/study/NCT05580562","title":"ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study","has_exemption":false,"start_date":"2023-01-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05701774","publication_url":"https://clinicaltrials.gov/study/NCT05701774","title":"An Open-Label Study of DCCR (Diazoxide Choline) Extended-Release Tablets in Patients With Prader-Willi Syndrome","has_exemption":false,"start_date":"2023-01-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Soleno Therapeutics, Inc.","sponsor_slug":"soleno-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04930887","publication_url":"https://clinicaltrials.gov/study/NCT04930887","title":"Prospective, Randomized, Double-blinded, Placebo-controlled, Cross-over Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) Towards the Ipsilateral Pterygopalatine Fossa for the Treatment of Craniofacial Pain","has_exemption":false,"start_date":"2023-02-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05461547","publication_url":"https://clinicaltrials.gov/study/NCT05461547","title":"Pre-Hospital Lung Ultrasound Impact on Diagnosis","has_exemption":false,"start_date":"2023-02-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05685238","publication_url":"https://clinicaltrials.gov/study/NCT05685238","title":"Open-label, Long-term Safety and Efficacy Study of Mim8 in Participants With Haemophilia A With or Without Inhibitors","has_exemption":false,"start_date":"2023-02-13","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317000","publication_url":"https://clinicaltrials.gov/study/NCT05317000","title":"A Window Trial of 5-Azacytidine or Nivolumab or Combination Nivolumab Plus 5-Azacytidine in Resectable HPV-Associated Head and Neck Squamous Cell Cancer","has_exemption":false,"start_date":"2023-03-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Barbara Burtness","sponsor_slug":"barbara-burtness","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05239546","publication_url":"https://clinicaltrials.gov/study/NCT05239546","title":"Phase II, Single Arm Study of Neoadjuvant Dostarlimab (TSR-042) in Stage II and III Deficient Mismatch Repair Colon Cancers","has_exemption":false,"start_date":"2023-03-24","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05786924","publication_url":"https://clinicaltrials.gov/study/NCT05786924","title":"A Phase 1/2, Open-label Study of Oral S241656 (BDTX-4933) as Monotherapy and in Combination With Other Anti-Cancer Therapies in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies","has_exemption":false,"start_date":"2023-04-18","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Institut de Recherches Internationales Servier","sponsor_slug":"institut-de-recherches-internationales-servier","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05918835","publication_url":"https://clinicaltrials.gov/study/NCT05918835","title":"Deciphering the Neural Mechanisms of Restrictive Eating in Anorexia Nervosa Using Repetitive Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2023-04-24","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05732103","publication_url":"https://clinicaltrials.gov/study/NCT05732103","title":"Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients With Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2023-04-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Chordia Therapeutics, Inc.","sponsor_slug":"chordia-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05956951","publication_url":"https://clinicaltrials.gov/study/NCT05956951","title":"Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Closed-Loop Auditory Stimulation","has_exemption":false,"start_date":"2023-07-20","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Fabio Ferrarelli","sponsor_slug":"fabio-ferrarelli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05981755","publication_url":"https://clinicaltrials.gov/study/NCT05981755","title":"Breathing Rescue for SUDEP Prevention (BreatheS)","has_exemption":false,"start_date":"2023-07-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05602194","publication_url":"https://clinicaltrials.gov/study/NCT05602194","title":"A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy","has_exemption":false,"start_date":"2023-08-14","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06013956","publication_url":"https://clinicaltrials.gov/study/NCT06013956","title":"Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinson's Disease Using Real-Time Neural Control","has_exemption":false,"start_date":"2023-08-29","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"David Escobar","sponsor_slug":"david-escobar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05883748","publication_url":"https://clinicaltrials.gov/study/NCT05883748","title":"HELIOS: An Open-Label, Long-Term Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)","has_exemption":false,"start_date":"2023-08-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Disc Medicine, Inc","sponsor_slug":"disc-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796453","publication_url":"https://clinicaltrials.gov/study/NCT05796453","title":"Long-term Evaluation of Safety and Performance of Clareon Presbyopia-Correcting Intraocular Lenses (IOLs)","has_exemption":false,"start_date":"2023-09-19","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05920798","publication_url":"https://clinicaltrials.gov/study/NCT05920798","title":"MC220601, Folate Receptor Alpha Dendritic Cells (FRαDCs) Plus Pembrolizumab for Patients With Advanced Stage Ovarian Cancer (FRAPPE)","has_exemption":false,"start_date":"2023-09-28","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05478707","publication_url":"https://clinicaltrials.gov/study/NCT05478707","title":"Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes","has_exemption":false,"start_date":"2023-10-05","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06060613","publication_url":"https://clinicaltrials.gov/study/NCT06060613","title":"A Phase 1/2, Open-Label Study to Investigate the Safety and Efficacy of Membrane Bound IL15 Expressing Tumor-Infiltrating Lymphocytes (OBX-115) In Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-10-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Obsidian Therapeutics, Inc.","sponsor_slug":"obsidian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05953090","publication_url":"https://clinicaltrials.gov/study/NCT05953090","title":"VALOR: Vaginal Atrophy & Long-term Observation of Recovery","has_exemption":false,"start_date":"2023-10-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Stratpharma AG","sponsor_slug":"stratpharma-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05912621","publication_url":"https://clinicaltrials.gov/study/NCT05912621","title":"Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity","has_exemption":false,"start_date":"2023-11-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662188","publication_url":"https://clinicaltrials.gov/study/NCT06662188","title":"A Phase 1/2, Multicenter, Open-Label, Dose-Escalation, Safety, Tolerability, and Clinical Activity Study of a Single Dose of JAG201 Gene Therapy Delivered Via Intracerebroventricular Administration in Participants With SHANK3 Haploinsufficiency","has_exemption":false,"start_date":"2024-01-07","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Jaguar Gene Therapy, LLC","sponsor_slug":"jaguar-gene-therapy-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05855330","publication_url":"https://clinicaltrials.gov/study/NCT05855330","title":"Prospective Open-Label Pilot Study of Arginine Replacement Therapy in Children Hospitalized With COVID-19","has_exemption":false,"start_date":"2024-01-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05573490","publication_url":"https://clinicaltrials.gov/study/NCT05573490","title":"Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study","has_exemption":false,"start_date":"2024-01-11","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06038630","publication_url":"https://clinicaltrials.gov/study/NCT06038630","title":"129Xe Gas Exchange MRI to Visualize Cardiopulmonary Function","has_exemption":false,"start_date":"2024-01-12","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Bastiaan Driehuys","sponsor_slug":"bastiaan-driehuys","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06262438","publication_url":"https://clinicaltrials.gov/study/NCT06262438","title":"A Phase II, Single Arm, Open Label, Study on the Safety, Efficacy, Pharmacokinetics & Pharmacodynamics of Quizartinib + Chemotherapy and as Single-agent After High Dose Therapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients","has_exemption":false,"start_date":"2024-02-06","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Princess Maxima Center for Pediatric Oncology","sponsor_slug":"princess-maxima-center-for-pediatric-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06013384","publication_url":"https://clinicaltrials.gov/study/NCT06013384","title":"Clinical Feasibility of Low Intensity Focused Ultrasound Pulsation for the Treatment of Treatment Resistant Major Depressive Disorder","has_exemption":false,"start_date":"2024-02-16","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05772013","publication_url":"https://clinicaltrials.gov/study/NCT05772013","title":"Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations (OPACE): A Double Blind Adaptive Design Pragmatic Phase IV Randomised Controlled Trial","has_exemption":false,"start_date":"2024-03-05","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Dr Ian B Wilkinson","sponsor_slug":"dr-ian-b-wilkinson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06256588","publication_url":"https://clinicaltrials.gov/study/NCT06256588","title":"A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate Dostarlimab as Sequential Therapy After Chemoradiation in Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2024-03-21","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06051695","publication_url":"https://clinicaltrials.gov/study/NCT06051695","title":"A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Autologous Logic-gated Tmod™ CAR T Products, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression","has_exemption":false,"start_date":"2024-04-03","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"A2 Biotherapeutics Inc.","sponsor_slug":"a2-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055608","publication_url":"https://clinicaltrials.gov/study/NCT06055608","title":"Advancing Transplantation Outcomes in Children (CTOT-41)","has_exemption":false,"start_date":"2024-05-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06419374","publication_url":"https://clinicaltrials.gov/study/NCT06419374","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ENLIGHTEN-Cirrhosis)","has_exemption":false,"start_date":"2024-05-24","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"89bio, Inc.","sponsor_slug":"89bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510582","publication_url":"https://clinicaltrials.gov/study/NCT06510582","title":"Chronic Subdural Hematoma Treatment With Avastin® (Bevacizumab) Intra-Arterial Injection: A Non-Randomized, Open-Label Phase 1/2 Clinical Trial","has_exemption":false,"start_date":"2024-06-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"The Cooper Health System","sponsor_slug":"the-cooper-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05897424","publication_url":"https://clinicaltrials.gov/study/NCT05897424","title":"A Phase 2, Single Arm, Open Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency (AATD) Emphysema","has_exemption":false,"start_date":"2024-06-20","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453460","publication_url":"https://clinicaltrials.gov/study/NCT06453460","title":"Prospective Evaluation of Efficacy of CMV-specific T Cell Immunity (CMV-TCIP) Directed Letermovir Prophylaxis After Allogeneic Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2024-06-27","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06001658","publication_url":"https://clinicaltrials.gov/study/NCT06001658","title":"Tumor Microenvironment Features of Response to Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers","has_exemption":false,"start_date":"2024-07-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333990","publication_url":"https://clinicaltrials.gov/study/NCT06333990","title":"A Randomized Clinical Trial of Quetiapine to Reduce Post Concussive Syndrome Polypharmacy","has_exemption":false,"start_date":"2024-07-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Foundation for Advancing Veterans' Health Research","sponsor_slug":"foundation-for-advancing-veterans-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113016","publication_url":"https://clinicaltrials.gov/study/NCT06113016","title":"A Phase II Randomized Placebo-Controlled Study of Fisetin and Exercise to Prevent Frailty in Breast Cancer Survivors","has_exemption":false,"start_date":"2024-07-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510374","publication_url":"https://clinicaltrials.gov/study/NCT06510374","title":"A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Ferring Pharmaceuticals","sponsor_slug":"ferring-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06545955","publication_url":"https://clinicaltrials.gov/study/NCT06545955","title":"A Phase 3, Randomised, Multi-center, Open Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade Bacillus Calmette-Guerin Therapy (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Ferring Pharmaceuticals","sponsor_slug":"ferring-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327490","publication_url":"https://clinicaltrials.gov/study/NCT06327490","title":"A Pilot Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer","has_exemption":false,"start_date":"2024-10-15","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06544499","publication_url":"https://clinicaltrials.gov/study/NCT06544499","title":"A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia","has_exemption":false,"start_date":"2024-10-18","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06598397","publication_url":"https://clinicaltrials.gov/study/NCT06598397","title":"Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care","has_exemption":false,"start_date":"2024-10-18","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"New York University","sponsor_slug":"new-york-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06010719","publication_url":"https://clinicaltrials.gov/study/NCT06010719","title":"Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition: the AMOUR Trial","has_exemption":false,"start_date":"2024-10-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06544408","publication_url":"https://clinicaltrials.gov/study/NCT06544408","title":"Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation","has_exemption":false,"start_date":"2024-11-06","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05986578","publication_url":"https://clinicaltrials.gov/study/NCT05986578","title":"Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder","has_exemption":false,"start_date":"2024-11-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05656235","publication_url":"https://clinicaltrials.gov/study/NCT05656235","title":"Renal Retention in High Grade Upper Tract Urothelial Cancer: A Phase II Trial of Enfortumab Vedotin and Pembrolizumab in Patients With Upper Tract Urothelial Cancer (UTUC) Who Are Not Candidates for, or Refuse, Nephroureterectomy","has_exemption":false,"start_date":"2024-11-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06575751","publication_url":"https://clinicaltrials.gov/study/NCT06575751","title":"Cannabidiol and Cannabis Concentrate Users: A Randomized, Placebo Controlled Study","has_exemption":false,"start_date":"2024-12-04","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06441890","publication_url":"https://clinicaltrials.gov/study/NCT06441890","title":"BRE-10: BIomarker OptimizatioN of NeOadjuVAnt Therapy in BrEast Cancer: The INNOVATE Trial","has_exemption":false,"start_date":"2024-12-05","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569394","publication_url":"https://clinicaltrials.gov/study/NCT06569394","title":"A Randomized, Placebo Controlled Study of Cannabidiol in Young Adult Cannabis Users","has_exemption":false,"start_date":"2024-12-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727604","publication_url":"https://clinicaltrials.gov/study/NCT06727604","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease","has_exemption":false,"start_date":"2024-12-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06635902","publication_url":"https://clinicaltrials.gov/study/NCT06635902","title":"A Phase 2 Randomized Double-blind, Placebo-controlled Clinical Trial of Intravenous Citrulline for Vaso-occlusive Pain Episode in Hospitalized Patients With Sickle Cell Disease (CONQUER SCD Pain Trial)","has_exemption":false,"start_date":"2024-12-22","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Suvankar Majumdar","sponsor_slug":"suvankar-majumdar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588478","publication_url":"https://clinicaltrials.gov/study/NCT06588478","title":"A Phase 2, Open-Label, Randomized Study Evaluating the Efficacy and Safety of 3 Doses of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who Previously Received Treatment With a Covalent Bruton Tyrosine Kinase Inhibitor","has_exemption":false,"start_date":"2025-01-03","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Loxo Oncology, Inc.","sponsor_slug":"loxo-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06767683","publication_url":"https://clinicaltrials.gov/study/NCT06767683","title":"An Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Durability of Treatment Effect of ALKS 2680 in Subjects With Narcolepsy Type 1 and Type 2 and Idiopathic Hypersomnia","has_exemption":false,"start_date":"2025-01-27","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580145","publication_url":"https://clinicaltrials.gov/study/NCT06580145","title":"Leucine as a Probe of Kynurenine-Induced Glutamate and Neural Circuit Dysfunction in Midlife Depression","has_exemption":false,"start_date":"2025-02-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06785636","publication_url":"https://clinicaltrials.gov/study/NCT06785636","title":"A Phase 1b/2a, MultiCenter, Open- Label Study of Pocenbrodib as Monotherapy or in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-02-07","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Pathos AI, Inc.","sponsor_slug":"pathos-ai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06105684","publication_url":"https://clinicaltrials.gov/study/NCT06105684","title":"Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer","has_exemption":false,"start_date":"2025-02-14","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06475781","publication_url":"https://clinicaltrials.gov/study/NCT06475781","title":"A Multinational Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Mirivadelgat, an Aldehyde Dehydrogenase 2 Activator, in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","has_exemption":false,"start_date":"2025-03-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Foresee Pharmaceuticals Co., Ltd.","sponsor_slug":"foresee-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06840483","publication_url":"https://clinicaltrials.gov/study/NCT06840483","title":"Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer","has_exemption":false,"start_date":"2025-03-03","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"BicycleTx Limited","sponsor_slug":"bicycletx-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926920","publication_url":"https://clinicaltrials.gov/study/NCT06926920","title":"A Phase 1/2, Open-label Study of Sacituzumab Govitecan Administered at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer","has_exemption":false,"start_date":"2025-04-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06687161","publication_url":"https://clinicaltrials.gov/study/NCT06687161","title":"Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI","has_exemption":false,"start_date":"2025-05-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06747845","publication_url":"https://clinicaltrials.gov/study/NCT06747845","title":"ParpVax2: A Phase II Study Of Maintenance Niraparib Plus Ipilimumab In Patients With Metastatic Pancreatic Cancer Whose Disease Has Not Progressed On Platinum-Based Therapy","has_exemption":false,"start_date":"2025-05-07","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06697314","publication_url":"https://clinicaltrials.gov/study/NCT06697314","title":"Prospective, Multicenter, Multi-national, Single Arm Trial Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System","has_exemption":false,"start_date":"2025-06-15","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Angiodynamics, Inc.","sponsor_slug":"angiodynamics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06934538","publication_url":"https://clinicaltrials.gov/study/NCT06934538","title":"Open Label, Multicenter, Dose-escalation and Cohort-expansion Phase I/IIA Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer (CRC) - BreAK CRC Trial (BreAK for Brenus Anti-cancer)","has_exemption":false,"start_date":"2025-06-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Brenus Pharma","sponsor_slug":"brenus-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07037459","publication_url":"https://clinicaltrials.gov/study/NCT07037459","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)","has_exemption":false,"start_date":"2025-06-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06649890","publication_url":"https://clinicaltrials.gov/study/NCT06649890","title":"A Randomized Control Trial Evaluating the Efficacy of Xperience™ Surgical Irrigation Solution Versus Dilute Povidone-Iodine in Preventing Surgical Site Infections and Improving Postoperative Outcomes in Implant-Based Breast Reconstruction","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06254469","publication_url":"https://clinicaltrials.gov/study/NCT06254469","title":"Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease","has_exemption":false,"start_date":"2025-07-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"CereMark Pharma, LLC","sponsor_slug":"ceremark-pharma-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06997068","publication_url":"https://clinicaltrials.gov/study/NCT06997068","title":"MC240701 Decentralized Pilot Study of Triple Oral Metronomic Chemotherapy for Patients With Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population","has_exemption":false,"start_date":"2025-07-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07105358","publication_url":"https://clinicaltrials.gov/study/NCT07105358","title":"Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training","has_exemption":false,"start_date":"2025-07-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06859424","publication_url":"https://clinicaltrials.gov/study/NCT06859424","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","has_exemption":false,"start_date":"2025-07-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Center for International Blood and Marrow Transplant Research","sponsor_slug":"center-for-international-blood-and-marrow-transplant-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07037433","publication_url":"https://clinicaltrials.gov/study/NCT07037433","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity","has_exemption":false,"start_date":"2025-07-25","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07126262","publication_url":"https://clinicaltrials.gov/study/NCT07126262","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Vosoritide in Infants and Young Children With Hypochondroplasia, Aged 0 to < 36 Months","has_exemption":false,"start_date":"2025-07-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219784","publication_url":"https://clinicaltrials.gov/study/NCT07219784","title":"Abdominal Binders to Minimize Enteral Nutrition Disruptions for Preterm Infants On Non-Invasive Respiratory Support","has_exemption":false,"start_date":"2025-07-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07049341","publication_url":"https://clinicaltrials.gov/study/NCT07049341","title":"Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases","has_exemption":false,"start_date":"2025-07-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"NeuroEM Therapeutics, Inc.","sponsor_slug":"neuroem-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06732401","publication_url":"https://clinicaltrials.gov/study/NCT06732401","title":"A Randomized Phase III Trial of Checkpoint Blockade in Lung Cancer Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)","has_exemption":false,"start_date":"2025-08-07","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07172516","publication_url":"https://clinicaltrials.gov/study/NCT07172516","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Azetukalner in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)","has_exemption":false,"start_date":"2025-08-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084558","publication_url":"https://clinicaltrials.gov/study/NCT07084558","title":"ABCSG 61 / TEODOR (Neoadjuvant TrEatment Optimization Driven by ctDNA and endOcrine Responsiveness): A Prospective, Randomized, Controlled, Openlabel Multicenter Phase II Study Investigating Neoadjuvant Endocrine Therapy Versus Chemotherapy in HR-positive, HER2negative, ctDNA-negative and Endocrine Responsive Early and Locally Advanced Breast Cancer","has_exemption":false,"start_date":"2025-08-13","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Austrian Breast & Colorectal Cancer Study Group","sponsor_slug":"austrian-breast-colorectal-cancer-study-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06188923","publication_url":"https://clinicaltrials.gov/study/NCT06188923","title":"A New Intervention to Improve Function in Veterans With Anxiety and Depression","has_exemption":false,"start_date":"2025-08-14","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06432166","publication_url":"https://clinicaltrials.gov/study/NCT06432166","title":"2-Hydroxybenzylamine (2-HOBA) Phase 1b/2a Proof-of Concept, Dose-Finding, Biomarker Study in Early Alzheimer's Patients","has_exemption":false,"start_date":"2025-09-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"MTI Biotech Inc","sponsor_slug":"mti-biotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06942754","publication_url":"https://clinicaltrials.gov/study/NCT06942754","title":"Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial (BRACE-trial)","has_exemption":false,"start_date":"2025-09-11","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205887","publication_url":"https://clinicaltrials.gov/study/NCT07205887","title":"A Phase 2 Randomized, Dose-Masked Study of Intravitreal EYE103 in Participants With Neovascular Age-Related Macular Degeneration (NVAMD) or Macular Edema Following Branch Retinal Vein Occlusion (BRVO)","has_exemption":false,"start_date":"2025-09-12","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"EyeBiotech Ltd.","sponsor_slug":"eyebiotech-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06366230","publication_url":"https://clinicaltrials.gov/study/NCT06366230","title":"Adding Urea to the Final Dialysis Fluid in Order to Prevent Dialysis Disequilibrium in Patients Who Need Aggressive Dialysis for Electrolyte Abnormalities","has_exemption":false,"start_date":"2025-09-16","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216430","publication_url":"https://clinicaltrials.gov/study/NCT07216430","title":"A Phase 2 Study Evaluating the Safety and Efficacy of Whole-Cell Pneumococcal Vaccine (wSp) in Reducing Nasopharyngeal Colonization by Streptococcus Pneumoniae in Young Children.","has_exemption":false,"start_date":"2025-09-29","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Serum Life Science Europe GmbH","sponsor_slug":"serum-life-science-europe-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223593","publication_url":"https://clinicaltrials.gov/study/NCT07223593","title":"A Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Peripheral Artery Disease: A Randomized, Double-Blind, Placebo Controlled Trial","has_exemption":false,"start_date":"2025-10-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07146438","publication_url":"https://clinicaltrials.gov/study/NCT07146438","title":"Precision Medicine for OCD - Biobehavioral Tracking of Transcranial Magnetic Stimulation (TMS) With Exposure and Response Prevention (ERP) for Refractory OCD","has_exemption":false,"start_date":"2025-11-10","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Adam Frank","sponsor_slug":"adam-frank","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06930625","publication_url":"https://clinicaltrials.gov/study/NCT06930625","title":"A Phase 3 Randomized 3-arm Trial (Double-blind Debio 4126, Placebo Control, and Open-label Debio 4126), to Assess the Efficacy and Safety of Debio 4126, a 12-week Octreotide Formulation, in Patients With Acromegaly Previously Treated With Somatostatin Analogs","has_exemption":false,"start_date":"2025-11-26","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Debiopharm International SA","sponsor_slug":"debiopharm-international-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218146","publication_url":"https://clinicaltrials.gov/study/NCT07218146","title":"A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-11-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Zai Lab (Shanghai) Co., Ltd.","sponsor_slug":"zai-lab-shanghai-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07401095","publication_url":"https://clinicaltrials.gov/study/NCT07401095","title":"Early Outcomes With and Without Use of a Novel Reinforced Bioinductive Implant in Arthroscopic Brostrom Repair: A Prospective Randomized Study","has_exemption":false,"start_date":"2025-12-08","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Hancock Orthopedics","sponsor_slug":"hancock-orthopedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07189936","publication_url":"https://clinicaltrials.gov/study/NCT07189936","title":"Mechanism of Isolevuglandin-Protein Adduct Formation in Persistent Immune Activation in Long COVID POTS","has_exemption":false,"start_date":"2025-12-18","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06683729","publication_url":"https://clinicaltrials.gov/study/NCT06683729","title":"HighLife Clarity Treatment of Severe Mitral Regurgitation","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"HighLife SAS","sponsor_slug":"highlife-sas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789302","publication_url":"https://clinicaltrials.gov/study/NCT06789302","title":"A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2025-12-31","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Global Institute of Stem Cell Therapy and Research","sponsor_slug":"global-institute-of-stem-cell-therapy-and-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596434","publication_url":"https://clinicaltrials.gov/study/NCT06596434","title":"4-Aminopyridine to Treat Skin Burns","has_exemption":false,"start_date":"2026-01-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"John Elfar","sponsor_slug":"john-elfar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07266402","publication_url":"https://clinicaltrials.gov/study/NCT07266402","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study of Barzolvolimab in Participants With Cold Induced Urticaria and Symptomatic Dermographism (EMBARQ-COLDU and SD)","has_exemption":false,"start_date":"2026-01-15","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Celldex Therapeutics","sponsor_slug":"celldex-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06614322","publication_url":"https://clinicaltrials.gov/study/NCT06614322","title":"Sensory Phenotyping to Enhance Neuropathic Pain Drug Development (SPENDD): A Randomized, Double-blinded Cross-over Clinical Trial Aimed at Investigating Whether Bedside Quantitative Sensory Testing Can Predict Response to Analgesics.","has_exemption":false,"start_date":"2026-01-29","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07182032","publication_url":"https://clinicaltrials.gov/study/NCT07182032","title":"Ketamine Use in Central Sensitization: a Study Evaluating the Use of Ketamine in Centrally Sensitized Endometriosis Patients","has_exemption":false,"start_date":"2026-02-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07392190","publication_url":"https://clinicaltrials.gov/study/NCT07392190","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Persistent Obesity or Overweight Treated With a Weekly Incretin, With and Without Type 2 Diabetes","has_exemption":false,"start_date":"2026-02-10","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07495852","publication_url":"https://clinicaltrials.gov/study/NCT07495852","title":"Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","has_exemption":false,"start_date":"2026-02-17","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204184","publication_url":"https://clinicaltrials.gov/study/NCT07204184","title":"Cervical and Lumbosacral Transspinal Stimulation to Reconnect the Injured Human Spinal Cord","has_exemption":false,"start_date":"2026-02-19","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Maria Knikou, PT, MBA, PhD","sponsor_slug":"maria-knikou-pt-mba-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07432022","publication_url":"https://clinicaltrials.gov/study/NCT07432022","title":"A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EMB-07 (a Bispecific Antibody Targeting CD3 and Receptor-tyrosine-kinase-like Orphan Receptor 1 [ROR1]) Combination Therapy in Patients With Aggressive B-cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Shanghai EpimAb Biotherapeutics Co., Ltd.","sponsor_slug":"shanghai-epimab-biotherapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288398","publication_url":"https://clinicaltrials.gov/study/NCT07288398","title":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction","has_exemption":false,"start_date":"2026-03-03","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Tenax Therapeutics, Inc.","sponsor_slug":"tenax-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07491445","publication_url":"https://clinicaltrials.gov/study/NCT07491445","title":"RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel Versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients With Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-03-09","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07467473","publication_url":"https://clinicaltrials.gov/study/NCT07467473","title":"Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression","has_exemption":false,"start_date":"2026-03-23","completion_date":"2028-06-30","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null}]}